Brain Injury and Neurovascular Pathologies Study Section – BINP
The Brain Injury and Neurovascular Pathologies (BINP) Study Section reviews applications that investigate mechanisms of acute brain injury and to test potential therapies in animal models of ischemic stroke, cerebral ischemia, traumatic brain injury, and related vascular disorders, including cerebral amyloid angiopathy, intracerebral hemorrhage, microvascular damage, vascular cognitive impairment, and alterations in the blood brain barrier.
The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
Review Dates
Topics
- Development of novel in vitro models of acute neural injury.
- Identification and analysis of function or dysfunction of neuronal and nonneuronal cellular and molecular mechanisms and signal transduction pathways.
- A role for blood brain barrier and vascular functions including cerebral blood flow in development and treatment of neural injury
- Mechanisms of post stroke injury and recovery
- Post injury neuroplasticity, injury-induced neurogenesis and angiogenesis
- Cerebrovascular disease-related cognitive impairment
- Identification of novel therapeutic targets, neuroprotective agents and therapeutic strategies, including stem cell therapy, to prevent and treat acute brain injury.
- Elucidating roles for age, gender, genetics, and environment in response to and recovery from acute brain injury.
Shared Interests and Overlaps
Cellular and Molecular Biology of Glia (CMBG) reviews basic cellular and molecular functions concerning blood brain barrier vs. BINP reviews disease related functions.
There are shared interests in cerebrovascular disease (CVD)/TBI/hypoxic/ischemic stroke with Brain Injury and Neurovascular Disorders (BIND), and Developmental Brain Disorders (DBD). Applications that emphasize the use of experimental and preclinical animal models are reviewed in BINP. Applications that primarily emphasize clinical and human-subject based studies (also imaging-heavy proposals in this context) are reviewed in BIND. Applications that emphasize pediatric TBI/hypoxic/ischemia (primarily neurodevelopmental effects) are reviewed in DBD.
CVD – BINP reviews applications focused on the mechanisms involved in the disease vs Chronic Dysfunction and Integrative Neurodegeneration (CDIN) reviews applications focused on cognitive impairment, dementia, and Alzheimer’s Disease
There are shared interests of BINP with Atherosclerosis and Vascular Inflammation (AVI), Integrative Vascular Physiology and Pathology (IVPP) and Hemostasis, Thrombosis, Blood Cells and Transfusion Study Section (HTBT). Applications that emphasize atherosclerosis-related mechanisms of vascular aging will be reviewed in AVI. Applications that emphasize stroke, microcirculation and flow related to hypertension may be assigned to IVPP. Applications that emphasize coagulation factors in intracranial hemorrhage/clot formation may be assigned to HTBT. Applications focused on the blood brain barrier and vascular function in the treatment of neural injury and post-stroke recovery are reviewed in BINP.
